Sarepta Therapeutics | SRPT - 이자 수익

주가
17.16
매일 변경
0.32 1.90%
매월
-7.69%
매년
-78.54%
Q1 예상
15.90




이자 수익 변화 날짜
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Daiichi Sankyo JPY 9.96B 230M 2024-03
Eli Lilly USD 65M 25M 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Gilead Sciences USD 88M 15M 2025-09
Incyte USD 30.75M 3.97M 2025-12
Insmed USD 765K 55K 2024-09
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Moderna USD 73M 8M 2025-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Novavax USD 303K 27K 2021-12
Pfizer USD 0.62 156M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09